Janine L. Mansi
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
The utility of electronic frailty index in cancer patients undergoing chemotherapy.
Journal: British journal of cancer
Published: July 28, 2025
Alpelisib-Induced Late-Onset Diabetic Ketoacidosis in Advanced Breast Cancer.
Journal: Diabetes care
Published: March 12, 2025
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Journal: Nature communications
Published: March 06, 2025
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Journal: Nature communications
Published: August 07, 2023
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 30, 2022
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Journal: Nature communications
Published: September 27, 2022
Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: August 22, 2022
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 15, 2021
The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 2: breast cancer.
Journal: British dental journal
Published: December 14, 2020
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
Journal: Clinical breast cancer
Published: September 10, 2020
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 05, 2020
Reply: Relevance of Measurement Uncertainty for Quantitative Response Assessment of Breast Cancer Bone Metastases with 18F-Fluoride.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 10, 2019
Last Updated: 09/26/2026